Medical Care

Global CD81 Antibody Market Research Report 2025

The global market for CD81 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD81 antibody is a mouse, rabbit, pig and human antibody against CD81. CD81 was recognized in immunohistochemical staining and western blot.
Growing patient base, launch of novel CD81 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD81 antibody market revenue.
This report aims to provide a comprehensive presentation of the global market for CD81 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD81 Antibody.
The CD81 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD81 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD81 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Thermo Fisher Scientific
LifeSpan BioSciences
BosterBio
Proteintech Group
Leading Biology
RayBiotech
Bioss
GeneTex
BioLegend
Leinco Technologies
Bio-Rad
NSJ Bioreagents
ABclonal Technology
Cell Signaling Technology
EpiGentek
SouthernBiotech
Abbexa
R and D Systems
Novus Biologicals
Abnova Corporation
HUABIO
Miltenyi Biotec
Enzo Life Sciences
Aviva Systems Biology
Wuhan Fine Biotech
Biobyt
Beijing Solarbio
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD81 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD81 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD81 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD81 Antibody Market Perspective (2020-2031)
2.2 Global CD81 Antibody Growth Trends by Region
2.2.1 Global CD81 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD81 Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD81 Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD81 Antibody Market Dynamics
2.3.1 CD81 Antibody Industry Trends
2.3.2 CD81 Antibody Market Drivers
2.3.3 CD81 Antibody Market Challenges
2.3.4 CD81 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD81 Antibody Players by Revenue
3.1.1 Global Top CD81 Antibody Players by Revenue (2020-2025)
3.1.2 Global CD81 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD81 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD81 Antibody Revenue
3.4 Global CD81 Antibody Market Concentration Ratio
3.4.1 Global CD81 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD81 Antibody Revenue in 2024
3.5 Global Key Players of CD81 Antibody Head office and Area Served
3.6 Global Key Players of CD81 Antibody, Product and Application
3.7 Global Key Players of CD81 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD81 Antibody Breakdown Data by Type
4.1 Global CD81 Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD81 Antibody Forecasted Market Size by Type (2026-2031)
5 CD81 Antibody Breakdown Data by Application
5.1 Global CD81 Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD81 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD81 Antibody Market Size (2020-2031)
6.2 North America CD81 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD81 Antibody Market Size by Country (2020-2025)
6.4 North America CD81 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD81 Antibody Market Size (2020-2031)
7.2 Europe CD81 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD81 Antibody Market Size by Country (2020-2025)
7.4 Europe CD81 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD81 Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD81 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD81 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD81 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD81 Antibody Market Size (2020-2031)
9.2 Latin America CD81 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD81 Antibody Market Size by Country (2020-2025)
9.4 Latin America CD81 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD81 Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD81 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD81 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD81 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD81 Antibody Introduction
11.1.4 Merck Revenue in CD81 Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD81 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD81 Antibody Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 LifeSpan BioSciences
11.3.1 LifeSpan BioSciences Company Details
11.3.2 LifeSpan BioSciences Business Overview
11.3.3 LifeSpan BioSciences CD81 Antibody Introduction
11.3.4 LifeSpan BioSciences Revenue in CD81 Antibody Business (2020-2025)
11.3.5 LifeSpan BioSciences Recent Development
11.4 BosterBio
11.4.1 BosterBio Company Details
11.4.2 BosterBio Business Overview
11.4.3 BosterBio CD81 Antibody Introduction
11.4.4 BosterBio Revenue in CD81 Antibody Business (2020-2025)
11.4.5 BosterBio Recent Development
11.5 Proteintech Group
11.5.1 Proteintech Group Company Details
11.5.2 Proteintech Group Business Overview
11.5.3 Proteintech Group CD81 Antibody Introduction
11.5.4 Proteintech Group Revenue in CD81 Antibody Business (2020-2025)
11.5.5 Proteintech Group Recent Development
11.6 Leading Biology
11.6.1 Leading Biology Company Details
11.6.2 Leading Biology Business Overview
11.6.3 Leading Biology CD81 Antibody Introduction
11.6.4 Leading Biology Revenue in CD81 Antibody Business (2020-2025)
11.6.5 Leading Biology Recent Development
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech CD81 Antibody Introduction
11.7.4 RayBiotech Revenue in CD81 Antibody Business (2020-2025)
11.7.5 RayBiotech Recent Development
11.8 Bioss
11.8.1 Bioss Company Details
11.8.2 Bioss Business Overview
11.8.3 Bioss CD81 Antibody Introduction
11.8.4 Bioss Revenue in CD81 Antibody Business (2020-2025)
11.8.5 Bioss Recent Development
11.9 GeneTex
11.9.1 GeneTex Company Details
11.9.2 GeneTex Business Overview
11.9.3 GeneTex CD81 Antibody Introduction
11.9.4 GeneTex Revenue in CD81 Antibody Business (2020-2025)
11.9.5 GeneTex Recent Development
11.10 BioLegend
11.10.1 BioLegend Company Details
11.10.2 BioLegend Business Overview
11.10.3 BioLegend CD81 Antibody Introduction
11.10.4 BioLegend Revenue in CD81 Antibody Business (2020-2025)
11.10.5 BioLegend Recent Development
11.11 Leinco Technologies
11.11.1 Leinco Technologies Company Details
11.11.2 Leinco Technologies Business Overview
11.11.3 Leinco Technologies CD81 Antibody Introduction
11.11.4 Leinco Technologies Revenue in CD81 Antibody Business (2020-2025)
11.11.5 Leinco Technologies Recent Development
11.12 Bio-Rad
11.12.1 Bio-Rad Company Details
11.12.2 Bio-Rad Business Overview
11.12.3 Bio-Rad CD81 Antibody Introduction
11.12.4 Bio-Rad Revenue in CD81 Antibody Business (2020-2025)
11.12.5 Bio-Rad Recent Development
11.13 NSJ Bioreagents
11.13.1 NSJ Bioreagents Company Details
11.13.2 NSJ Bioreagents Business Overview
11.13.3 NSJ Bioreagents CD81 Antibody Introduction
11.13.4 NSJ Bioreagents Revenue in CD81 Antibody Business (2020-2025)
11.13.5 NSJ Bioreagents Recent Development
11.14 ABclonal Technology
11.14.1 ABclonal Technology Company Details
11.14.2 ABclonal Technology Business Overview
11.14.3 ABclonal Technology CD81 Antibody Introduction
11.14.4 ABclonal Technology Revenue in CD81 Antibody Business (2020-2025)
11.14.5 ABclonal Technology Recent Development
11.15 Cell Signaling Technology
11.15.1 Cell Signaling Technology Company Details
11.15.2 Cell Signaling Technology Business Overview
11.15.3 Cell Signaling Technology CD81 Antibody Introduction
11.15.4 Cell Signaling Technology Revenue in CD81 Antibody Business (2020-2025)
11.15.5 Cell Signaling Technology Recent Development
11.16 EpiGentek
11.16.1 EpiGentek Company Details
11.16.2 EpiGentek Business Overview
11.16.3 EpiGentek CD81 Antibody Introduction
11.16.4 EpiGentek Revenue in CD81 Antibody Business (2020-2025)
11.16.5 EpiGentek Recent Development
11.17 SouthernBiotech
11.17.1 SouthernBiotech Company Details
11.17.2 SouthernBiotech Business Overview
11.17.3 SouthernBiotech CD81 Antibody Introduction
11.17.4 SouthernBiotech Revenue in CD81 Antibody Business (2020-2025)
11.17.5 SouthernBiotech Recent Development
11.18 Abbexa
11.18.1 Abbexa Company Details
11.18.2 Abbexa Business Overview
11.18.3 Abbexa CD81 Antibody Introduction
11.18.4 Abbexa Revenue in CD81 Antibody Business (2020-2025)
11.18.5 Abbexa Recent Development
11.19 R and D Systems
11.19.1 R and D Systems Company Details
11.19.2 R and D Systems Business Overview
11.19.3 R and D Systems CD81 Antibody Introduction
11.19.4 R and D Systems Revenue in CD81 Antibody Business (2020-2025)
11.19.5 R and D Systems Recent Development
11.20 Novus Biologicals
11.20.1 Novus Biologicals Company Details
11.20.2 Novus Biologicals Business Overview
11.20.3 Novus Biologicals CD81 Antibody Introduction
11.20.4 Novus Biologicals Revenue in CD81 Antibody Business (2020-2025)
11.20.5 Novus Biologicals Recent Development
11.21 Abnova Corporation
11.21.1 Abnova Corporation Company Details
11.21.2 Abnova Corporation Business Overview
11.21.3 Abnova Corporation CD81 Antibody Introduction
11.21.4 Abnova Corporation Revenue in CD81 Antibody Business (2020-2025)
11.21.5 Abnova Corporation Recent Development
11.22 HUABIO
11.22.1 HUABIO Company Details
11.22.2 HUABIO Business Overview
11.22.3 HUABIO CD81 Antibody Introduction
11.22.4 HUABIO Revenue in CD81 Antibody Business (2020-2025)
11.22.5 HUABIO Recent Development
11.23 Miltenyi Biotec
11.23.1 Miltenyi Biotec Company Details
11.23.2 Miltenyi Biotec Business Overview
11.23.3 Miltenyi Biotec CD81 Antibody Introduction
11.23.4 Miltenyi Biotec Revenue in CD81 Antibody Business (2020-2025)
11.23.5 Miltenyi Biotec Recent Development
11.24 Enzo Life Sciences
11.24.1 Enzo Life Sciences Company Details
11.24.2 Enzo Life Sciences Business Overview
11.24.3 Enzo Life Sciences CD81 Antibody Introduction
11.24.4 Enzo Life Sciences Revenue in CD81 Antibody Business (2020-2025)
11.24.5 Enzo Life Sciences Recent Development
11.25 Aviva Systems Biology
11.25.1 Aviva Systems Biology Company Details
11.25.2 Aviva Systems Biology Business Overview
11.25.3 Aviva Systems Biology CD81 Antibody Introduction
11.25.4 Aviva Systems Biology Revenue in CD81 Antibody Business (2020-2025)
11.25.5 Aviva Systems Biology Recent Development
11.26 Wuhan Fine Biotech
11.26.1 Wuhan Fine Biotech Company Details
11.26.2 Wuhan Fine Biotech Business Overview
11.26.3 Wuhan Fine Biotech CD81 Antibody Introduction
11.26.4 Wuhan Fine Biotech Revenue in CD81 Antibody Business (2020-2025)
11.26.5 Wuhan Fine Biotech Recent Development
11.27 Biobyt
11.27.1 Biobyt Company Details
11.27.2 Biobyt Business Overview
11.27.3 Biobyt CD81 Antibody Introduction
11.27.4 Biobyt Revenue in CD81 Antibody Business (2020-2025)
11.27.5 Biobyt Recent Development
11.28 Beijing Solarbio
11.28.1 Beijing Solarbio Company Details
11.28.2 Beijing Solarbio Business Overview
11.28.3 Beijing Solarbio CD81 Antibody Introduction
11.28.4 Beijing Solarbio Revenue in CD81 Antibody Business (2020-2025)
11.28.5 Beijing Solarbio Recent Development
11.29 Jingjie PTM BioLab
11.29.1 Jingjie PTM BioLab Company Details
11.29.2 Jingjie PTM BioLab Business Overview
11.29.3 Jingjie PTM BioLab CD81 Antibody Introduction
11.29.4 Jingjie PTM BioLab Revenue in CD81 Antibody Business (2020-2025)
11.29.5 Jingjie PTM BioLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CD81 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD81 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global CD81 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CD81 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global CD81 Antibody Market Share by Region (2020-2025)
Table 8. Global CD81 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global CD81 Antibody Market Share by Region (2026-2031)
Table 10. CD81 Antibody Market Trends
Table 11. CD81 Antibody Market Drivers
Table 12. CD81 Antibody Market Challenges
Table 13. CD81 Antibody Market Restraints
Table 14. Global CD81 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global CD81 Antibody Market Share by Players (2020-2025)
Table 16. Global Top CD81 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD81 Antibody as of 2024)
Table 17. Ranking of Global Top CD81 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by CD81 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of CD81 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD81 Antibody, Product and Application
Table 21. Global Key Players of CD81 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD81 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global CD81 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global CD81 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global CD81 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global CD81 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global CD81 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global CD81 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global CD81 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America CD81 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America CD81 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America CD81 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe CD81 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe CD81 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe CD81 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific CD81 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific CD81 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific CD81 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD81 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America CD81 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America CD81 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa CD81 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa CD81 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa CD81 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck CD81 Antibody Product
Table 49. Merck Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CD81 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. LifeSpan BioSciences Company Details
Table 57. LifeSpan BioSciences Business Overview
Table 58. LifeSpan BioSciences CD81 Antibody Product
Table 59. LifeSpan BioSciences Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 60. LifeSpan BioSciences Recent Development
Table 61. BosterBio Company Details
Table 62. BosterBio Business Overview
Table 63. BosterBio CD81 Antibody Product
Table 64. BosterBio Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 65. BosterBio Recent Development
Table 66. Proteintech Group Company Details
Table 67. Proteintech Group Business Overview
Table 68. Proteintech Group CD81 Antibody Product
Table 69. Proteintech Group Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 70. Proteintech Group Recent Development
Table 71. Leading Biology Company Details
Table 72. Leading Biology Business Overview
Table 73. Leading Biology CD81 Antibody Product
Table 74. Leading Biology Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 75. Leading Biology Recent Development
Table 76. RayBiotech Company Details
Table 77. RayBiotech Business Overview
Table 78. RayBiotech CD81 Antibody Product
Table 79. RayBiotech Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 80. RayBiotech Recent Development
Table 81. Bioss Company Details
Table 82. Bioss Business Overview
Table 83. Bioss CD81 Antibody Product
Table 84. Bioss Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 85. Bioss Recent Development
Table 86. GeneTex Company Details
Table 87. GeneTex Business Overview
Table 88. GeneTex CD81 Antibody Product
Table 89. GeneTex Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 90. GeneTex Recent Development
Table 91. BioLegend Company Details
Table 92. BioLegend Business Overview
Table 93. BioLegend CD81 Antibody Product
Table 94. BioLegend Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 95. BioLegend Recent Development
Table 96. Leinco Technologies Company Details
Table 97. Leinco Technologies Business Overview
Table 98. Leinco Technologies CD81 Antibody Product
Table 99. Leinco Technologies Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 100. Leinco Technologies Recent Development
Table 101. Bio-Rad Company Details
Table 102. Bio-Rad Business Overview
Table 103. Bio-Rad CD81 Antibody Product
Table 104. Bio-Rad Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 105. Bio-Rad Recent Development
Table 106. NSJ Bioreagents Company Details
Table 107. NSJ Bioreagents Business Overview
Table 108. NSJ Bioreagents CD81 Antibody Product
Table 109. NSJ Bioreagents Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 110. NSJ Bioreagents Recent Development
Table 111. ABclonal Technology Company Details
Table 112. ABclonal Technology Business Overview
Table 113. ABclonal Technology CD81 Antibody Product
Table 114. ABclonal Technology Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 115. ABclonal Technology Recent Development
Table 116. Cell Signaling Technology Company Details
Table 117. Cell Signaling Technology Business Overview
Table 118. Cell Signaling Technology CD81 Antibody Product
Table 119. Cell Signaling Technology Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 120. Cell Signaling Technology Recent Development
Table 121. EpiGentek Company Details
Table 122. EpiGentek Business Overview
Table 123. EpiGentek CD81 Antibody Product
Table 124. EpiGentek Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 125. EpiGentek Recent Development
Table 126. SouthernBiotech Company Details
Table 127. SouthernBiotech Business Overview
Table 128. SouthernBiotech CD81 Antibody Product
Table 129. SouthernBiotech Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 130. SouthernBiotech Recent Development
Table 131. Abbexa Company Details
Table 132. Abbexa Business Overview
Table 133. Abbexa CD81 Antibody Product
Table 134. Abbexa Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 135. Abbexa Recent Development
Table 136. R and D Systems Company Details
Table 137. R and D Systems Business Overview
Table 138. R and D Systems CD81 Antibody Product
Table 139. R and D Systems Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 140. R and D Systems Recent Development
Table 141. Novus Biologicals Company Details
Table 142. Novus Biologicals Business Overview
Table 143. Novus Biologicals CD81 Antibody Product
Table 144. Novus Biologicals Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 145. Novus Biologicals Recent Development
Table 146. Abnova Corporation Company Details
Table 147. Abnova Corporation Business Overview
Table 148. Abnova Corporation CD81 Antibody Product
Table 149. Abnova Corporation Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 150. Abnova Corporation Recent Development
Table 151. HUABIO Company Details
Table 152. HUABIO Business Overview
Table 153. HUABIO CD81 Antibody Product
Table 154. HUABIO Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 155. HUABIO Recent Development
Table 156. Miltenyi Biotec Company Details
Table 157. Miltenyi Biotec Business Overview
Table 158. Miltenyi Biotec CD81 Antibody Product
Table 159. Miltenyi Biotec Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 160. Miltenyi Biotec Recent Development
Table 161. Enzo Life Sciences Company Details
Table 162. Enzo Life Sciences Business Overview
Table 163. Enzo Life Sciences CD81 Antibody Product
Table 164. Enzo Life Sciences Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 165. Enzo Life Sciences Recent Development
Table 166. Aviva Systems Biology Company Details
Table 167. Aviva Systems Biology Business Overview
Table 168. Aviva Systems Biology CD81 Antibody Product
Table 169. Aviva Systems Biology Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 170. Aviva Systems Biology Recent Development
Table 171. Wuhan Fine Biotech Company Details
Table 172. Wuhan Fine Biotech Business Overview
Table 173. Wuhan Fine Biotech CD81 Antibody Product
Table 174. Wuhan Fine Biotech Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 175. Wuhan Fine Biotech Recent Development
Table 176. Biobyt Company Details
Table 177. Biobyt Business Overview
Table 178. Biobyt CD81 Antibody Product
Table 179. Biobyt Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 180. Biobyt Recent Development
Table 181. Beijing Solarbio Company Details
Table 182. Beijing Solarbio Business Overview
Table 183. Beijing Solarbio CD81 Antibody Product
Table 184. Beijing Solarbio Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 185. Beijing Solarbio Recent Development
Table 186. Jingjie PTM BioLab Company Details
Table 187. Jingjie PTM BioLab Business Overview
Table 188. Jingjie PTM BioLab CD81 Antibody Product
Table 189. Jingjie PTM BioLab Revenue in CD81 Antibody Business (2020-2025) & (US$ Million)
Table 190. Jingjie PTM BioLab Recent Development
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
Table 194. Authors List of This Report


List of Figures
Figure 1. CD81 Antibody Picture
Figure 2. Global CD81 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD81 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global CD81 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global CD81 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. CD81 Antibody Report Years Considered
Figure 15. Global CD81 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CD81 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CD81 Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global CD81 Antibody Market Share by Players in 2024
Figure 19. Global Top CD81 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD81 Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CD81 Antibody Revenue in 2024
Figure 21. North America CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CD81 Antibody Market Share by Country (2020-2031)
Figure 23. United States CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CD81 Antibody Market Share by Country (2020-2031)
Figure 27. Germany CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CD81 Antibody Market Share by Region (2020-2031)
Figure 35. China CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CD81 Antibody Market Share by Country (2020-2031)
Figure 43. Mexico CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CD81 Antibody Market Share by Country (2020-2031)
Figure 47. Turkey CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CD81 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 52. LifeSpan BioSciences Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 53. BosterBio Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 54. Proteintech Group Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 55. Leading Biology Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 56. RayBiotech Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 57. Bioss Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 58. GeneTex Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 59. BioLegend Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 60. Leinco Technologies Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 61. Bio-Rad Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 62. NSJ Bioreagents Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 63. ABclonal Technology Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 64. Cell Signaling Technology Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 65. EpiGentek Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 66. SouthernBiotech Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 67. Abbexa Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 68. R and D Systems Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 69. Novus Biologicals Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 70. Abnova Corporation Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 71. HUABIO Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 72. Miltenyi Biotec Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 73. Enzo Life Sciences Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 74. Aviva Systems Biology Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 75. Wuhan Fine Biotech Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 76. Biobyt Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 77. Beijing Solarbio Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 78. Jingjie PTM BioLab Revenue Growth Rate in CD81 Antibody Business (2020-2025)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies